Application of nervous necrosis virus capsid protein-based antigen-presenting particles for vaccine development

被引:0
作者
Wayha, Sajee [1 ]
Koiwai, Keiichiro [1 ]
Sano, Motohiko [1 ]
Hirono, Ikuo [1 ]
Kondo, Hidehiro [1 ]
机构
[1] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo 1088477, Japan
关键词
Nervous necrosis virus; Capsid protein; Virus-like particles; Vaccine; Japanese flounder; SEA-BASS; IMMUNE-RESPONSE; DNA VACCINE; CELL-DEATH; NODAVIRUS; EXPRESSION; ADJUVANT; FISH;
D O I
10.1016/j.fsi.2024.109803
中图分类号
S9 [水产、渔业];
学科分类号
0908 ;
摘要
Nervous necrosis virus (NNV) capsid protein plays an important role in producing viral particles without any genetic elements. Thus, NNV is a promising candidate for vaccine development and is widely used for constructing vaccines, including DNA, recombinant proteins, and virus-like particles (VLPs). Our study aimed to investigate the potential of NNV capsid protein (NNV) and NNV capsid protein fused to enhanced green fluorescent protein (NNV-EGFP) through VLP formation and whether their application can induce specific antibody responses against certain antigens. We focused on producing DNA and recombinant protein vaccines consisting of the genes for NNV, EGFP, and NNV-EGFP. The approach using NNV-EGFP allowed NNV to act as a carrier or inducer while EGFP was incorporated as part of the capsid protein, thereby enhancing the immune response. In vitro studies demonstrated that all DNA vaccines expressed in HINAE cells resulted in varying protein expression levels, with particularly low levels observed for pNNV and pNNV-EGFP. Consequently, structural proteins derived from HINAE cells could not be observed using transmission electron microscopy (TEM). In contrast, recombinant proteins of NNV and NNV-EGFP were expressed through the Escherichia coli expression system. TEM revealed that rNNV was assembled into VLPs with an approximate size of 30 nm, whereas rNNV-EGFP presented particles ranging from 10 nm to 50 nm in size. For the vaccination test, DNA vaccination marginally induced specific antibody responses in Japanese flounder compared to unvaccinated fish. Meanwhile, NNV and NNVEGFP recombinant vaccines enhanced a greater anti-NNV antibody response than the others, whereas antibody responses against EGFP were also marginal. These results indicate that NNV capsid protein-based antigens, presenting as particles, play an important role in eliciting a specific anti-NNV antibody response and have the potential to improve fish immune responses.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Development of a candidate vaccine for Newcastle disease virus by epitope display in the Cucumber mosaic virus capsid protein
    Yan Zhao
    Rosemarie W. Hammond
    Biotechnology Letters, 2005, 27 : 375 - 382
  • [32] Inhibition of the antigen-presenting ability of dendritic cells by non-structural protein 2 of influenza A virus
    Lin, Jian
    Cao, Yanan
    Zuo, Jinjiao
    Zhang, Shuai
    Yu, Qinghua
    Yang, Qian
    Shaha, Abid Ullah
    Chong, Mark M. W.
    VETERINARY MICROBIOLOGY, 2022, 267
  • [33] ADNA Vaccine That Encodes an Antigen-Presenting Cell-Specific Heterodimeric Protein Protects against Cancer and Influenza
    Braathen, Ranveig
    Spang, Heidi Cecilie Larsen
    Hinke, Daniela Maria
    Blazevski, Jana
    Bobic, Sonja
    Fossum, Even
    Bogen, Bjarne
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 17 : 378 - 392
  • [34] Development of a candidate vaccine for Newcastle disease virus by epitope display in the Cucumber mosaic virus capsid protein
    Zhao, Y
    Hammond, RW
    BIOTECHNOLOGY LETTERS, 2005, 27 (06) : 375 - 382
  • [35] Development of membrane protein-based vaccine against lumpy skin disease virus (LSDV) using immunoinformatic tools
    Salauddin, Md.
    Kayesh, Mohammad Enamul Hoque
    Ahammed, Md. Suruj
    Saha, Sukumar
    Hossain, Md. Golzar
    VETERINARY MEDICINE AND SCIENCE, 2024, 10 (03)
  • [36] Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine
    Blazevic, Vesna
    Malm, Maria
    Arinobu, Daisuke
    Lappalainen, Suvi
    Vesikari, Timo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (03) : 740 - 748
  • [37] Advancement in the development of gene/protein-based vaccines against African swine fever virus
    Wang, Ning
    Huang, Pan
    Zhang, Jun
    Lin, Minqi
    Lai, Xiaoru
    Chen, Jianwen
    Pan, Chungen
    CURRENT RESEARCH IN MICROBIAL SCIENCES, 2024, 6
  • [38] Antigen vehiculization particles based on the Z protein of Junin virus
    Borio, Cristina S.
    Bilen, Marcos F.
    Argueelles, Marcelo H.
    Goni, Sandra E.
    Iserte, Javier A.
    Glikmann, Graciela
    Lozano, Mario E.
    BMC BIOTECHNOLOGY, 2012, 12
  • [39] Antigen vehiculization particles based on the Z protein of Junin virus
    Cristina S Borio
    Marcos F Bilen
    Marcelo H Argüelles
    Sandra E Goñi
    Javier A Iserte
    Graciela Glikmann
    Mario E Lozano
    BMC Biotechnology, 12
  • [40] Formulation Development of a COVID-19 Recombinant Spike Protein-Based Vaccine
    Xiao, Emily
    Mirabel, Clementine
    Clenet, Didier
    Zhu, Shaolong
    James, Andrew
    Ettorre, Luciano
    Williams, Trevor
    Szeto, Jason
    Rahman, Nausheen
    Ausar, Salvador Fernando
    VACCINES, 2024, 12 (08)